From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer
White | Black | |||||
---|---|---|---|---|---|---|
O/E | Excess risk | Mean age at event | O/E | Excess risk | Mean age at event | |
All sites | 1.64# | 36.87 | 52.03 | 2.29# | 63.89 | 50.76 |
All solid tumors | 1.67# | 35.63 | 52.08 | 2.34# | 60.24 | 50.54 |
Oral cavity and pharynx | 1.57# | 0.49 | 53.33 | 0.29 | -0.59 | 63 |
Digestive system | 1.05 | 0.32 | 54.15 | 1.25 | 2.19 | 51.39 |
Colon, rectum and anus | 0.9 | −0.42 | 53.03 | 1.05 | 0.24 | 50.74 |
Pancreas | 1.41# | 0.35 | 56.16 | 1.33 | 0.35 | 56 |
Peritoneum, omentum and mesentery | 1.42 | 0.05 | 56.73 | 0 | −0.05 | |
Respiratory system | 1.37# | 1.83 | 55.38 | 1.56# | 3.15 | 52.2 |
Bones and joints | 1.62 | 0.06 | 47.4 | 3.69 | 0.17 | 49.25 |
Soft tissue including heart | 1.96# | 0.3 | 51.14 | 1.91 | 0.34 | 51.53 |
Skin excluding basal and squamous | 1.42# | 1.48 | 50.76 | 3.58 | 0.69 | 53.21 |
Breast | 2.22# | 27.6 | 51.43 | 3.53# | 49.01 | 49.75 |
Female genital system | 1.24# | 1.97 | 52.87 | 1.32 | 1.91 | 55.19 |
Corpus and uterus, NOS | 1.39# | 1.78 | 54.02 | 1.84# | 2.28 | 56.48 |
Ovary | 1.23# | 0.48 | 51.05 | 0.96 | −0.06 | 49.73 |
Urinary system | 1.35# | 0.75 | 54.28 | 1.88# | 1.56 | 51.6 |
Brain and other nervous system | 1.40# | 0.28 | 51.19 | 0 | −0.35 | |
Endocrine system | 1.26# | 0.78 | 49.27 | 2.58# | 2.77 | 47.17 |
Lymphoma | 1.04 | 0.09 | 53.13 | 1.04 | 0.08 | 54.76 |
Myeloma | 0.94 | −0.03 | 56.76 | 1.14 | 0.15 | 57.99 |
Leukemia | 1.89# | 0.88 | 47.48 | 3.04# | 1.44 | 52.46 |